Key result
Bilateral vs single internal thoracic artery grafting shows no mortality benefit, despite fewer strokes.
Why the study?
Concern about sternal wound complications limits bilateral internal thoracic artery (BITA) grafting, particularly in patients with diabetes and obesity, motivating an evaluation of mid-term outcomes of an extensive BITA grafting program in a region with high diabetes-related mortality.
Does bilateral internal thoracic artery (BITA) grafting improve mid-term survival and cardiovascular outcomes without increasing sternal wound complications compared to single internal thoracic artery (SITA) grafting in patients with a high burden of diabetes undergoing isolated multivessel CABG?
Cohort (n=667)
Does bilateral internal thoracic artery (BITA) grafting improve mid-term survival and cardiovascular outcomes without increasing sternal wound complications compared to single internal thoracic artery (SITA) grafting in patients with a high burden of diabetes undergoing isolated multivessel CABG?
In a population with nearly 50% diabetes prevalence undergoing multivessel CABG, extensive BITA grafting did not significantly increase sternal wound complications or improve mid-term survival compared to SITA grafting, but was associated with a lower rate of stroke.
Answers are grounded in this paper and cite their sources.
No mortality difference or excess sternal risk with BITA; should not change practice and leaves open need for randomized trials.
Background/Objectives: Concern about sternal wound complications limits bilateral internal thoracic artery (BITA) grafting, particularly in patients with diabetes and obesity. We evaluated the mid-term results of a program of extensive BITA grafting in the Canary Islands, the Spanish region with the highest diabetes-related mortality. Methods: We retrospectively analyzed 667 consecutive patients undergoing non-emergent, first-time, isolated multivessel coronary artery bypass grafting between 2017 and 2025; 472 (70.8%) received BITA and 195 (29.2%) single internal thoracic artery (SITA) grafting. Outcomes were compared using inverse probability of treatment weighting. Results: Half of the patients (49.8%) had diabetes. Median follow-up was 46.2 months. After weighting, BITA and SITA grafting did not differ in all-cause mortality (hazard ratio [HR] 0.90; 95% confidence interval [CI] 0.55–1.47; p = 0.68), myocardial infarction (HR 0.65; 95% CI 0.28–1.51), repeat revascularization (HR 0.76; 95% CI 0.32–1.83) or major adverse cardiovascular events (HR 0.81; 95% CI 0.52–1.25). Stroke was less frequent after BITA grafting (HR 0.24; 95% CI 0.07–0.77; p = 0.016). Sternal wound complications occurred in 8.7% vs. 6.2% of patients (odds ratio 1.45; 95% CI 0.75–2.82; p = 0.35), with no excess among patients with diabetes (8.8% vs. 8.7%). Conclusions: In a population with a high burden of diabetes, BITA grafting was delivered to 70.8% of unselected patients without a significant excess of sternal wound complications. It did not improve mid-term survival, but stroke was less frequent after BITA grafting, a hypothesis-generating finding that requires confirmation.
No takes yet. Share an insight, caveat, or question.
Rio et al. (2026) conducted a cohort in Multivessel coronary artery disease undergoing coronary artery bypass grafting (n=667). Bilateral internal thoracic artery (BITA) grafting vs. Single internal thoracic artery (SITA) grafting was evaluated on All-cause mortality (HR 0.90, 95% CI 0.55-1.47, p=0.68). Bilateral vs single internal thoracic artery grafting showed similar all-cause mortality and sternal complications, but lower stroke.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: